Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0000950129-07-001433
Filing Date
2007-03-16
Accepted
2007-03-16 17:20:02
Documents
6
Period of Report
2006-12-31

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO.1 TO FORM 10-K h44503a1e10vkza.htm 10-K/A 385369
2 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM h44503a1exv23w1.htm EX-23.1 3211
3 CERTIFICATION OF CHIEF EXECUTIVE OFFICER h44503a1exv31w1.htm EX-31.1 6989
4 CERTIFICATION OF CHIEF FINANCIAL OFFICER h44503a1exv31w2.htm EX-31.2 6472
5 CERTIFICATION PURSUANT TO SECTION 906 h44503a1exv32w1.htm EX-32.1 2464
6 CERTIFICATION PURSUANT TO SECTION 906 h44503a1exv32w2.htm EX-32.2 2404
  Complete submission text file 0000950129-07-001433.txt   408458
Mailing Address 4848 LOOP CENTRAL DRIVE SUITE 700 HOUSTON TX 77081
Business Address 4848 LOOP CENTRAL DRIVE SUITE 700 HOUSTON TX 77081 7137968822
ENCYSIVE PHARMACEUTICALS INC (Filer) CIK: 0000887023 (see all company filings)

EIN.: 133532643 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 000-20117 | Film No.: 07701208
SIC: 2834 Pharmaceutical Preparations